[Nutritional status and pulmonary function in children and adolescents with cystic fibrosis]

Wioleta Umławska1, Monika Krzyżanowska, Anna Zielińska

  • 1Katedra Biologii Czlowieka Uniwersytetu Wroclawskiego. wilota@antropo.uni.wroc.pl

Insights

Children with cystic fibrosis (CF) often experience growth issues and malnutrition, impacting their lung function. Addressing nutritional status is crucial for improving outcomes in pediatric CF patients.

Area of Science:

  • Pediatric Pulmonology
  • Nutritional Science
  • Genetics

Background:

  • Cystic fibrosis (CF) significantly impacts somatic development and respiratory function, crucial prognostic factors for lifespan.
  • Evaluating nutritional status and pulmonary function is vital for managing pediatric CF patients.

Purpose of the Study:

  • To assess nutritional status and pulmonary function in children and adolescents with CF.
  • To investigate the relationship between pulmonary function and disease course factors.

Main Methods:

  • Retrospective analysis of anthropometric and spirometric data from 89 pediatric CF patients.
  • CFTR gene mutation analysis and anthropometric parameter standardization against population references.

Main Results:

  • Studied children exhibited shorter stature and significant growth disturbances compared to healthy peers.
  • Nearly 50% of children were malnourished, showing deficits in muscle mass and adiposity.
  • Pulmonary function (percent predicted FEV1) was directly correlated with nutritional status, being highest in well-nourished and lowest in severely malnourished patients.

Conclusions:

  • Nutritional status significantly affects pulmonary function in pediatric CF patients.
  • Chronic Pseudomonas aeruginosa infection adversely impacts lung function.
Abstract

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...